January 17, 2025

Fast-tracking inhalation toxicology testing for the global market

Labcorp's expertise in inhalation toxicology and end-to-end early phase development solutions (EPDS) enabled a leading Japanese pharmaceutical company to fast-track the global development of a novel inhaled large-molecule drug. With plans to commercialize in various geographies across the world, the company needed a lab partner with specialized inhalation capabilities and global reach. Labcorp's extensive inhalation toxicology expertise, including experience with non-human primate models, positioned them as the ideal testing partner. Their EPDS team provided customized guidance and seamless coordination to accelerate the program. Through high-touch partnership and local representatives, Labcorp delivered tailored support that met the client's specific needs and challenges. This case study illustrates how Labcorp helped their client capitalize on the growing inhaled drug market and advance an important new therapy globally.
Read more »
January 17, 2025

In vitro chromosomal aberration assay: Unraveling the genetic puzzle to evaluate medical device safety at Labcorp’s Bedford Genetic Toxicology Laboratory

Genotoxicity testing is crucial for medical device safety. Labcorp's chromosomal aberration assay meticulously evaluates chromosomes to determine if a device causes genotoxic harm. This powerful tool assesses potential risks early in development, enabling manufacturers to mitigate risks before commercialization. The scientists at the GeneTox Laboratory in Bedford, Massachusetts, understand the intricacies of this test and offer it to sponsors for the evaluation of their medical devices, one chromosome at a time.
Read more »
January 8, 2025

LABCORP DECLARES QUARTERLY DIVIDEND

BURLINGTON, N.C. , Jan. 8, 2025 /PRNewswire/ --  Labcorp Holdings Inc.  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Read more »
January 7, 2025

Liquid Biopsy for Precision Oncology Summit 2025

Speaking Engagement
Thursday, February 20 at 10:00A.M.
 

Speaker: Erin Newburn, Ph.D. Senior Director, Field Applications Scientist

Title: Navigating challenges in utilizing ctDNA profiling for biomarker-driven therapy development

Summary

Read more »
<span>Four tips for better health in 2025</span>
January 3, 2025

Four tips for better health in 2025

According to a survey from the American Heart Association, 79% of respondents don’t prioritize their health during the holidays. In fact, they reported having greater stress during the holiday season than during the often-dreaded tax filing period. 
Read more »